Used as an intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to construct complex indazole-based scaffolds. These scaffolds are common in drug discovery for their biological activity, including kinase inhibition and anti-inflammatory properties. The boronate ester group enables coupling with aryl halides, allowing rapid diversification of molecular structures during lead optimization. Commonly applied in the development of oncology and CNS-targeted therapeutics. Stable and compatible with a range of reaction conditions, making it valuable in late-stage functionalization.